Cancer drug toxicity: Moving from patient to survivor

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Millions of individuals worldwide are living with cancer and have remained disease-free for more than 5 years. These individuals are considered to be cancer survivors. The advent of new targeted therapies and personalized treatment modalities have contributed to this increased survivorship. Additionally, earlier diagnosis and detection of cancer, greater access to preventive screenings, and greater focus on cancer pharmaceutical safety have all been contributed to increasing longevity. Of note, all cancer types have benefited in the survivorship arena. The advent of expansive survivorship care planning mandated by national governmental agencies and the emergence of newer classes of drug therapies for cancer are expected to buttress and support cancer survivorship in the coming decades.

Original languageEnglish (US)
Title of host publicationCancer Treatment and Research
PublisherSpringer International Publishing
Pages107-118
Number of pages12
DOIs
StatePublished - Jan 1 2019

Publication series

NameCancer Treatment and Research
Volume171
ISSN (Print)0927-3042

Fingerprint

Moving and Lifting Patients
Drug-Related Side Effects and Adverse Reactions
Neoplasms
Early Detection of Cancer
Safety
Drug Therapy
Therapeutics
Pharmaceutical Preparations

Keywords

  • Cancer
  • Drug policy
  • Pharmaceutical safety
  • Survivorship

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Slocum, M., Garcia, S. F., & McKoy, J. M. (2019). Cancer drug toxicity: Moving from patient to survivor. In Cancer Treatment and Research (pp. 107-118). (Cancer Treatment and Research; Vol. 171). Springer International Publishing. https://doi.org/10.1007/978-3-319-43896-2_8
Slocum, Megan ; Garcia, Sofia F ; McKoy, June M. / Cancer drug toxicity : Moving from patient to survivor. Cancer Treatment and Research. Springer International Publishing, 2019. pp. 107-118 (Cancer Treatment and Research).
@inbook{49eba35b199a4791b9c08af4491a6559,
title = "Cancer drug toxicity: Moving from patient to survivor",
abstract = "Millions of individuals worldwide are living with cancer and have remained disease-free for more than 5 years. These individuals are considered to be cancer survivors. The advent of new targeted therapies and personalized treatment modalities have contributed to this increased survivorship. Additionally, earlier diagnosis and detection of cancer, greater access to preventive screenings, and greater focus on cancer pharmaceutical safety have all been contributed to increasing longevity. Of note, all cancer types have benefited in the survivorship arena. The advent of expansive survivorship care planning mandated by national governmental agencies and the emergence of newer classes of drug therapies for cancer are expected to buttress and support cancer survivorship in the coming decades.",
keywords = "Cancer, Drug policy, Pharmaceutical safety, Survivorship",
author = "Megan Slocum and Garcia, {Sofia F} and McKoy, {June M}",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/978-3-319-43896-2_8",
language = "English (US)",
series = "Cancer Treatment and Research",
publisher = "Springer International Publishing",
pages = "107--118",
booktitle = "Cancer Treatment and Research",

}

Slocum, M, Garcia, SF & McKoy, JM 2019, Cancer drug toxicity: Moving from patient to survivor. in Cancer Treatment and Research. Cancer Treatment and Research, vol. 171, Springer International Publishing, pp. 107-118. https://doi.org/10.1007/978-3-319-43896-2_8

Cancer drug toxicity : Moving from patient to survivor. / Slocum, Megan; Garcia, Sofia F; McKoy, June M.

Cancer Treatment and Research. Springer International Publishing, 2019. p. 107-118 (Cancer Treatment and Research; Vol. 171).

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Cancer drug toxicity

T2 - Moving from patient to survivor

AU - Slocum, Megan

AU - Garcia, Sofia F

AU - McKoy, June M

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Millions of individuals worldwide are living with cancer and have remained disease-free for more than 5 years. These individuals are considered to be cancer survivors. The advent of new targeted therapies and personalized treatment modalities have contributed to this increased survivorship. Additionally, earlier diagnosis and detection of cancer, greater access to preventive screenings, and greater focus on cancer pharmaceutical safety have all been contributed to increasing longevity. Of note, all cancer types have benefited in the survivorship arena. The advent of expansive survivorship care planning mandated by national governmental agencies and the emergence of newer classes of drug therapies for cancer are expected to buttress and support cancer survivorship in the coming decades.

AB - Millions of individuals worldwide are living with cancer and have remained disease-free for more than 5 years. These individuals are considered to be cancer survivors. The advent of new targeted therapies and personalized treatment modalities have contributed to this increased survivorship. Additionally, earlier diagnosis and detection of cancer, greater access to preventive screenings, and greater focus on cancer pharmaceutical safety have all been contributed to increasing longevity. Of note, all cancer types have benefited in the survivorship arena. The advent of expansive survivorship care planning mandated by national governmental agencies and the emergence of newer classes of drug therapies for cancer are expected to buttress and support cancer survivorship in the coming decades.

KW - Cancer

KW - Drug policy

KW - Pharmaceutical safety

KW - Survivorship

UR - http://www.scopus.com/inward/record.url?scp=85058974637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058974637&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-43896-2_8

DO - 10.1007/978-3-319-43896-2_8

M3 - Chapter

T3 - Cancer Treatment and Research

SP - 107

EP - 118

BT - Cancer Treatment and Research

PB - Springer International Publishing

ER -

Slocum M, Garcia SF, McKoy JM. Cancer drug toxicity: Moving from patient to survivor. In Cancer Treatment and Research. Springer International Publishing. 2019. p. 107-118. (Cancer Treatment and Research). https://doi.org/10.1007/978-3-319-43896-2_8